ASX:PAA - PharmAust New cancer treatment available for dogs with Lymphoma

Wednesday, November 6, 2019 9:40 PM +00:00

ASX:PAA - PharmAust New cancer treatment avai...0:0012:43
LIVEQuality1  AudioSubtitleDownloadSpeed1  
PHARMAUST LIMITED
Roger Aston

PharmAust Limited (ASX: PAA) is pleased to announce that its new clinical trial in partnership with U-Vet Werribee Animal Hospital is currently recruiting. The trial will evaluate the drug monepantel, which has shown promising anti-cancer results in vitro, in mice and in previous preliminary investigations in dogs with lymphoma as well as in a Phase I study in humans with cancer.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 20 Jan

    00:30

    Q4 2019 Schlumberger Earnings Conference Call 17 January 2020

    SCHLUMBERGER N.V.
  • 20 Jan

    00:30

    Oventus Medical Limited, sleep treatment platform roll-out

    OVENTUS MEDICAL LIMITED
  • 20 Jan

    02:00

    Fastenal Company Annual & Fourth Quarter 2019 Earnings Results Conference Call 17 January 2020

    FASTENAL COMPANY
  • 20 Jan

    02:00

    Investor Stream chats with: Indiana Resources Non-Executive Chair Bronwyn Barnes 17 January 2020

    INDIANA RESOURCES LIMITED
  • 20 Jan

    02:00

    Brandon Munro - When the Needle Starts Clickin' it's Where I'm Gonna Dig

    BANNERMAN RESOURCES LIMITED